June 2008 Volume 4, Issue 6

Volume 4, Issue 6 | June 2008

June 2008

In this Issue

Informatics

Drug Discovery News Placeholder Image

One-stop data shop

LabVantage, InforSense integrate data management and analytics platforms
Drug Discovery News Placeholder Image

From bedside to bench

GenoLogics develops translational research software for Fred Hutchinson Center
Drug Discovery News Placeholder Image

Best of both worlds

ClinPhone and invivodata align ePRO solutions
Drug Discovery News Placeholder Image

Parkinson’s research 2.0

The Parkinson’s Institute, 23andMe launch Web-based research initiative
Drug Discovery News Placeholder Image

The fat cell syndicate

Entelos lends PhysioLab model to Pfizer diabetes consortium

Research & Development

Drug Discovery News Placeholder Image

On their own again

Pfizer sells cholesterol therapy-focused Esperion Therapeutics
Drug Discovery News Placeholder Image

A midnight discovery

Minerva stumbles upon cancer therapy breakthrough
Drug Discovery News Placeholder Image

Profit for non-profit

SFBR launches for-profit drug company focused on women’s health concerns
Drug Discovery News Placeholder Image

UF compound lowers blood pressure

University of Florida researchers have identified a drug compound that may prevent tissue damage associated with cardiovascular disease, according to a study published in the May 1 edition of the American Heart Association journal Hypertension.
Drug Discovery News Placeholder Image

A one-two diabetes punch

DiaKine and Kinexum to develop novel combo treatment for type 1 diabetes

Global News

Drug Discovery News Placeholder Image

BMS to buy Kosan for $190M

BMS enhances cancer portfolio in two important anti-cancer classes
Drug Discovery News Placeholder Image

Takeda strikes deal with Alnylam

Non-exclusive platform deal could eventually net Alnylam $1 billion
Drug Discovery News Placeholder Image

Protecting your genome

Congress passes and president signs genetic antidiscrimination bill

Genomics & Proteomics

Drug Discovery News Placeholder Image

Cancer cohorts

Researchers around the world launch the International Cancer Genome Consortium
Drug Discovery News Placeholder Image

Yerkes’ monkey business

Researchers develop first transgenic nonhuman primate model of Huntington’s disease
Drug Discovery News Placeholder Image

Oligo-ing above and beyond

Agilent and Broad team up on genome-partitioning kits
Drug Discovery News Placeholder Image

Lipid mania

Lipidoids offer novel RNAi therapy delivery
Drug Discovery News Placeholder Image

Hope springs eternal for Benitec’s IP

City of Hope trial helps Benitec to rebuild its RNAi strength

Editor's Focus

Drug Discovery News Placeholder Image

Strange bedfellows: Bill Gates and Chairman Mao

News recently out of a discussion at the The Royal Society, London, is raising hopes that an effective and affordable cure for malaria is now on the horizon. But what do both Bill Gates and Chairman Mao have to do with this story? Well, plenty, if you follow the thread and history of malaria treatments.

Patent News

Drug Discovery News Placeholder Image

Is it difficult to do deals with universities?

Like many things in life, it’s always easy to criticize the other side. So, what is true?

Commentary

Drug Discovery News Placeholder Image

Today’s biopharma venture capital challenge: Risk-sharing models versus risk avoidance

In times like these, when the pendulum of fear swings to risk avoidance, biopharma can only develop products that meet both customer needs and Wall Street expectations through innovative, novel product development based on a reconsidered approach to risk management.

Feature

Drug Discovery News Placeholder Image

Trials and tribulations

Effective recruiting for clinical trials requires a commitment to educating patients and physicians

Automation & Instrumentation

Drug Discovery News Placeholder Image

Geared up for GPCRs

DiscoveRx, Caliper team up on microfluidic, cell-based assay deal targeting GPCR researchers
Drug Discovery News Placeholder Image

Putting their ChIPs on the table

Illumina, Genpathway team up to offer whole-genome ChIP sequencing services
Drug Discovery News Placeholder Image

Invitrogen intros cell therapy biz unit

Invitrogen Corp., which has been steadily building its cell therapy expertise, announced in mid-May the formation of a separate cell therapy business unit focused on the specific needs of the clinical cell therapy market.
Drug Discovery News Placeholder Image

Promega and GeneCopoeia play tag

Companies combine HaloTag with human and mouse ORF sequences
Subscribe to Newsletter

Subscribe to our eNewsletters

Stay connected with all of the latest from Drug Discovery News.

Subscribe

Sponsored

An illustration of three immune cells attacking a cancer cell, representing the mechanism of chimeric antigen receptor-based cell therapy

Cell therapy's next frontiers

As cell therapy evolves rapidly, what advancements are on the horizon? 
An illustration of a human heart on top of a DNA strand

Reversing rejection: gene therapy in modern transplantation

Emerging gene editing approaches pave the way for safer, more successful transplants.
An 3D illustration of protein molecules in different colors

Identifying druggable therapeutic targets

Effective target identification is central to drug discovery, but finding the right drug target is not as simple as it may seem in theory. 
Drug Discovery News November 2024 Issue
Latest IssueVolume 20 • Issue 6 • November 2024

November 2024

November 2024 Issue

Explore this issue